SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-12-062514
Filing Date
2012-11-14
Accepted
2012-11-14 16:08:30
Documents
10
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q v326466_10q.htm 10-Q 393978
2 EXHIBIT 10.1 v326466_ex10-1.htm EX-10.1 279935
3 EXHIBIT 31.1 v326466_ex31-1.htm EX-31.1 8075
4 EXHIBIT 32.1 v326466_ex32-1.htm EX-32.1 4745
  Complete submission text file 0001144204-12-062514.txt   2029675

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT rgrx-20120930.xml EX-101.INS 119999
6 XBRL TAXONOMY EXTENSION SCHEMA rgrx-20120930.xsd EX-101.SCH 20302
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rgrx-20120930_cal.xml EX-101.CAL 17422
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rgrx-20120930_def.xml EX-101.DEF 77090
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE rgrx-20120930_lab.xml EX-101.LAB 148474
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rgrx-20120930_pre.xml EX-101.PRE 102686
Mailing Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814
Business Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814 3019611992
REGENERX BIOPHARMACEUTICALS INC (Filer) CIK: 0000707511 (see all company filings)

IRS No.: 521253406 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-15070 | Film No.: 121204516
SIC: 2834 Pharmaceutical Preparations